Acid-Value Phospholipid Membranes for Sensitive-Skin Pore Care

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing pore and skin care products are either insufficiently effective, temporary, or burdensome, leading to further skin problems, and there is a lack of safe solutions for sensitive skin, particularly for issues like visible pores, acne, and skin redness, dullness, and wrinkles.

Innovation Solution

A lipid membrane structure formed from a phospholipid with an acid value of 5 mg KOH/g or more is used as a pore and skin improving agent, providing effects such as pore tightening, sebum regulation, acne suppression, and skin improvement without causing additional skin burden.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional pore improving agents (parakeratosis suppressing agents, pore tightening agents) are used, then pore problems are addressed, but the effects are insufficient and temporary, requiring continuous use which accumulates burden on skin

Engineering Contradiction:
Improveeffectiveness of pore improvementVSAvoidskin burden and irritation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the fundamental parameter of the active ingredient from conventional chemical compounds (parakeratosis suppressing agents, retinol derivatives) to a biological membrane structure (lipid membrane) composed of phospholipids. This parameter change enables the agent to integrate with skin's natural barrier function, providing sustained pore improvement without accumulating harmful effects through continuous use.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The lipid membrane structure acts as an intermediary that mediates between the active ingredients and the skin. It serves as a carrier and delivery system, allowing beneficial substances to be introduced while the membrane itself integrates with skin lipids, reducing irritation and burden while maintaining effectiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If high-concentration ethanol is used in combination with active ingredients, then the active ingredients can be delivered to skin, but skin problems and unsafe use occur especially in sensitive skin

Engineering Contradiction:
Improvedelivery efficiency of active ingredientsVSAvoidskin irritation and safety
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The phospholipid-based lipid membrane structure serves as a non-irritating intermediary carrier that replaces high-concentration ethanol as the delivery medium. It can transport active ingredients to the skin while being biocompatible and safe for sensitive skin, eliminating the harmful effects of ethanol-based delivery systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the delivery system parameter from high-concentration ethanol (alcoholic solvent) to phospholipid-based lipid membrane structures. This fundamental parameter change maintains delivery capability while eliminating irritation and safety issues associated with ethanol, especially for sensitive skin types.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If retinol-based components are used for pore improvement, then visible pores are effectively improved, but skin problems and long time for effects occur

Engineering Contradiction:
Improveeffectiveness of pore improvementVSAvoidtime for effects to manifest
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent changes the active ingredient parameter from retinol-based compounds to phospholipid-based lipid membrane structures. This parameter change enables immediate integration with skin barrier function, accelerating the time to see effects while maintaining pore improvement effectiveness through the membrane's natural role in skin maintenance.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250213450A1Pore improving agent and skin improving agent
Publication Date: 2025.07.03 T HASEGAWA CO LTD
  • US20250213450A1 patent drawing
  • US20250213450A1 patent drawing

AI summary

Provided is a pore improving agent comprising a composition containing a lipid membrane structure formed from a phospholipid having an acid value of 5 mg KOH/g or more. Also provided is a skin improving agent comprising a composition containing a lipid membrane structure formed from a phospholipid having an acid value of 5 mg KOH/g or more.